---
title: "JINYU and others established a supply chain company in Zhejiang"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251115812.md"
description: "According to the Qichacha APP, recently, Zhejiang Jinyu Baoling Supply Chain Co., Ltd. was established with a registered capital of 10 million yuan. Its business scope includes: supply chain management services; Internet of Things application services; research and development of biological feed, etc. Qichacha's equity penetration shows that the company is jointly held by JINYU's wholly-owned subsidiary Jinyu Baoling Biopharmaceutical Co., Ltd. and others"
datetime: "2025-08-01T05:27:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251115812.md)
  - [en](https://longbridge.com/en/news/251115812.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251115812.md)
---

# JINYU and others established a supply chain company in Zhejiang

According to the Qichacha APP, recently, Zhejiang Jinyu Baoling Supply Chain Co., Ltd. was established with a registered capital of 10 million yuan. Its business scope includes: supply chain management services; Internet of Things application services; research and development of biological feed, etc. Qichacha's equity penetration shows that the company is jointly held by JINYU's wholly-owned subsidiary Jinyu Baoling Biopharmaceutical Co., Ltd. and others

### Related Stocks

- [600201.CN](https://longbridge.com/en/quote/600201.CN.md)

## Related News & Research

- [06:06 ETWildlife experts offer seasonal tips to help orphaned or injured baby animals](https://longbridge.com/en/news/287197533.md)
- [ZAWYA: Kia’s global partner, The Ocean Cleanup expands plastic interception project ahead of LA28](https://longbridge.com/en/news/287182378.md)
- [BYD is struggling to meet demand for new fast-charging EVs as orders reach 100K, 60K](https://longbridge.com/en/news/287109883.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)